Disease Info Card

Lymphangioma, Cystic

Information about Lymphangioma, Cystic: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Lymphangioma, Cystic

Most recent studies have shown that Lymphangioma, Cystic shares some biological mechanisms with congenital-abnormality, cytogenetic-abnormality, edema, fetal-diseases, head-and-neck-neoplasms, hematoma, hematoma-subdural, hemorrhage, hydrocephalus, hydrops-fetalis, lymphangioma, mediastinal-neoplasms, neoplasms, pain, peritoneal-neoplasms, retroperitoneal-neoplasms, subdural-effusion, subdural-hygroma, trisomy, turner-syndrome.

Among the many pathways, these few ones have gauged particular interests from scientists studying Lymphangioma, Cystic, and have been seen in publications frequently: Cell Adhesion, Cell Migration, Coagulation, Cytokine Production, Dehiscence, Developmental Process, Enucleation, Fertilization, Fibrinolysis, Flight, Interphase, Localization, Lymphangiogenesis, Metaphase, Mitosis, Ossification, Pathogenesis, Secretion, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Lymphangioma, Cystic, such as ACHE, AFP, AVP, CD34, CP, CSF2, DCX, GLYAT, HBA1, LAMC2, NLRP5, NT5E, NTM, NTS, PECAM1, PPOX, SDS, SDSL, TRIM26. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.